18 January 2021, Geneva, Switzerland – The Stop TB Partnership launched today the Digital Health Technology Hub (DHT Hub), a unifying virtual platform that brings together the organization’s expertise and work in the digital health technology space to support the achievement of the United Nations High-Level Meeting on Tuberculosis (UNHLM on TB) commitments and targets.

The Stop TB Partnership released a video highlighting the work accomplished by TB REACH in 2020 in fighting TB while combating COVID-19.

Geneva, Switzerland, 11 December 2020 -  Only one in seven people in need of being tested for tuberculosis (TB) receive a rapid diagnostic test despite the fact that the first rapid molecular test for TB has now been in existence for a decade. As the GeneXpert test marks its 10th anniversary this week, the Stop TB Partnership calls for an emergency expansion of the use of rapid molecular diagnostics to ensure the speedy and efficient diagnosis of TB for all those that need it.

A communities report on progress towards the UN Political Declaration on the Fight Against TB and a Call to Action to close the gaps in TB targets

The report — Tuberculosis Research Funding Trends, 2005–2019 — presents new data on 2019 funding for TB research and development and analyzes trends in investment since 2005.

The Stop TB Partnership released its November 2020 newsletter, summarizing the initiatives and activities carried out during the month, including highlights from the 33rd Stop TB Partnership Board meeting, held virtually on 18-20 November 2020.

Over 300 representatives from countries, partners and civil society came together virtually at the Global Working Group Meeting on Public-Private Mix (PPM) on TB prevention and care on 23 and 25 November 2020. The Meeting was convened by the World Health Organization and the Stop TB Partnership with support from the U.S. Agency for International Development (USAID) and the Global Fund.

23 November 2020, KIEV, UKRAINE / THE HAGUE, NETHERLANDS: Ukraine is the first country in the world, under programmatic conditions, to provide tuberculosis (TB) patients with the groundbreaking new BPaL treatment. This three-drug treatment is meant for patients with extensively drug-resistant TB (XDR-TB) and is expected to have a higher success rate than previous treatments, doing away with painful daily injections. This deadly infectious disease currently ranks as the third cause of death in Ukraine among communicable, maternal, neonatal and nutritional diseases.

USD 7.5 million to support and bolster the fight against TB by civil society, community-based, and grassroots organizations for communities, rights and gender within the TB response through Challenge Facility for Civil Society was announced during the 33rd Stop TB Partnership Board meeting, held virtually on 18-20 November 2020. This represents a historic three-fold budget increase since Round 9.

Health Ministers from eleven African countries come together to define priority actions and financing needed to accelerate their TB responses.